TACSTD2 and hepatocellular carcinoma: In contrast, an opposite behaviour has been described for TACSTD2 mRNA and/or protein expression in cancer tissues in lung adenocarcinoma, head and neck squamous cell cancer (HNSCC) and hepatocellular carcinoma (HCC) when compared to the non-tumoral counterpart [31–33].